Where Will Myomo Inc (MYO) Stock Go Next After It Is Up 61.38% in a Week?

The market has been high on Myomo Inc (MYO) stock recently. MYO gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Myomo Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MYO!

See Full MYO Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With MYO Stock Today?

Myomo Inc (MYO) stock is trading at $3.05 as of 3:23 PM on Wednesday, Nov 15, a gain of $0.48, or 18.68% from the previous closing price of $2.57. The stock has traded between $2.62 and $3.15 so far today. Volume today is above average. So far 1,139,332 shares have traded compared to average volume of 306,503 shares. To screen for more stocks like Myomo Inc click here.

More About Myomo Inc

Myomo Inc is a medical robotics company. It develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. Myomo develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). The company's products are referred to patients at leading rehabilitation facilities, including Mayo Clinic, Cleveland Clinic, Massachusetts General Hospital, Kennedy Krieger Institute, Loma Linda Medical Center and twenty VA hospitals, among others. Click Here to get the full Stock Report for Myomo Inc stock.